Retinoids and chemoprevention of aerodigestive tract cancers

Cancer and Metastasis Reviews

Volumn 16, Issue 3-4, 1997, Pages 349-356

  Lotan, Reuben ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Aerodigestive; Cancer chemoprevention; Premalignant lesion; Retinoic acid; Retinoids

Indexed keywords

BENZO[A]PYRENE; BETA CAROTENE; CARCINOGEN; DIMETHYLBENZ[A]ANTHRACENE; ETRETINATE; FENRETINIDE; ISOTRETINOIN; MINERAL; MULTIVITAMIN; PLACEBO; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR; RETINOL; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL TISSUE; CARCINOGENESIS; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DRUG EFFICACY; ERYTHROPLASIA; ESOPHAGUS CANCER; HAMSTER; HEAD AND NECK CANCER; HUMAN; LARYNX PAPILLOMATOSIS; LEUKOPLAKIA; LUNG ALVEOLUS EPITHELIUM; LUNG CANCER; MOUTH CANCER; NONHUMAN; PRECANCER; PRIORITY JOURNAL; RAT; RETINOL DEFICIENCY; REVIEW; SECOND CANCER; SQUAMOUS CELL METAPLASIA;

EID: 0030681387     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1005808429176     Document Type: Review

References (40)

1. Parker SL, Tong T, Bolden S, Wingo PA: Cancer statistics, 1996. CA Cancer J Clin 46: 5-28, 1996
2. Bolt WJ, Devesa SS, Kneller RW: Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265: 1287-1289, 1991
3. Cameron AJ, Lomboy CT, Pera M, Carpenter HA: Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 109: 1541-1546, 1995
4. Mountain CF: A new international staging for lung cancer. Chest 89: 225s-233s, 1986
5. Flood WA, Forastiere AA: Esophagheal cancer. Curr Opinion in Oncol 7: 381-386, 1995
6. Gazdar AF: The molecular and cellular basis of human lung cancer. Anticancer Res 13: 261-168, 1994
7. Lippman SM, Benner SE, Hong WK: The chemoprevention of cancer. In: Greenwald P, Kramer RS, Weed DL (eds) Cancer Prevention and Control. Marcel Dekker, New York, 1995, pp 329-352
8. Hong WK, Itri LM: Retinoids and human cancer. In: Sporn MB, Roberts AB, Goodman DS (eds) The Retinoids. Raven Press, New York, 1994, pp 597-658
9. Hong WK, Lippman SM, Hittelman WN, Lotan R: Retinoid chemoprevention of aerodigestive cancer: From basic research to the clinic. Clin Cancer Res 1: 677-686, 1995
10. Moon RC, Mehta RG, Rao KJVN: Retinoids and cancer in experimental animals. In: Sporn MB, Roberts AB, Goodman DS (eds) The Retinoids. Raven Press, New York, 1994, pp 573-595
11. Steele VE, Kelloff GJ, Wilkinson BP, Arnold JT: Inhibition of transformation in cultured rat tracheal epithelial cells by potential chemopreventive agents. Cancer Res 50: 2068-2074, 1990
12. Crocker TT, Sanders LL: Cancer Res 30: 1312-1316, 1970
13. Shklar G, Schwartz J, Grau D, Trickler DP, Wallace KD: Inhibition of hamster buccal pouch carcinogenesis by 13-cis-retinoic acid. Oral Surg 50: 45-52, 1980
14. Goodwin WJ Jr, Huijing G, Bordash GD, Altman N: Inhibition of hamster tongue carcinogenesis by selenium and retinoic acid. Ann Otol Rhinol Laryngol 95: 162-166, 1986
15. Inoue I, Yamamoto Y, Ito T, Takahashi H: Chemoprevention of tongue carcinogenesis in rats. Oral Surg Oral Med Oral Pathol 76: 608-615, 1993
16. Heniford BW, Leonberger M, Ackermann DM, Handler FJ: Retinoic acid prevention of 4NQO induced oral squamous cell carcinogenesis. Soc Otolaryngol 1994
17. Lasnitzki I, Bollag W: Prevention and reversal by non-polar arotinoid (Ro 15-0778) of 3,4-benzopyrene- and cigarette smoke condensate-induced hyperplasia and metaplasia of rodent respiratory epithelia grown in vitro. Eur J Cancer Clin Oncol 23: 861-865, 1987
18. Beenken SW, Huang P, Sellers M, Peters G, Listinsky C, Stockard C, Hubbard W, Wheeler R, Grizzle W: Retinoid modulation of biomarkers in oral leukoplakia/dysplasia. J Cell Biochem (suppl) 19: 270-277, 1994
19. Chiesa F, Tradati N, Marazza M, Rossi N, Boracchi P, Mariani L, Formelli F, Giardini R, Costa A, De Palo G, Veronesi U: Fenretinide (4-HPR) in chemoprevention of oral leukoplakia. J Cell Biochem (suppl) 17F: 255-261, 1993
20. Tradati N, Chiesa F, Rossi N, Grigolato R, Formelli F, Costa A, de Palo G: Successful topical treatment of oral lichen planus and leukoplakias with fenretinide (4-HPR). Cancer Lett 76: 109-111, 1994
21. Costa A, Formelli F, Chiesa F, Decensi A, De Palo G, Veronesi U: Prospects of chemoprevention of human cancers with the synthetic retinoic fenretinide. Cancer Res (suppl) 54: 2032s-2037s, 1994
22. Auerbach O, Hammond EC, Garfinkel L: Changes in bronchial epithelium in relation to cigarette smoking, 1955-1960 vs. 1970-1977. N Engl J Med 300: 381-386, 1979
23. Lee JS, Lippman SM, Benner SE, Lee JJ, Ro JY, Lukeman JM, Morice RC, Peters EJ, Pang AC, Fritsche HA Jr, Hong WK: Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. J Clin Oncol 12: 937-945, 1994
24. Li JY, Taylor PR, Li B: Nutrition intervention trials in Linxian, China: Multiple vitamin/mineral supplementation, cancer incidence and disease-specific mortality among adults with esophageal dysplasia. J Natl Cancer Inst 85: 1492-1498, 1933
25. Blot WJ, Li JY, Taylor PR: Nutritional intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combination, cancer incidence and disease-specific mortality in the general population. J Natl Cancer Inst 85: 1483-1492, 1993
26. Han J: Highlights of the cancer chemoprevention studies in China. Prev Med 22: 712-722, 1993
27. Eicher SA, Taylor-Cooley LD, Donovan DT: Isotretinoin therapy for recurrent respiratory papillomatosis. Arch Otolaryngol Head & Neck Surg 120: 405-409, 1994
28. Bolla M, Lefur R, Ton Van J, Domenge C, Badet JM, Koskas Y, Laplanche A: Prevention of second primary tumours with etretinate in squamous cell carcinoma of the oral cavity and oropharynx. Results of a multicentric double-blind randomised study. Eur J Cancer 30A: 767-772, 1994
29. Pastorino U, Infante M, Maioli M, Chiesa G, Buyse M, Pirket P, Rosements N, Clerici M, Soresi E, Valente M, Belloni PA, Ravasi G: Adjuvant treatment of stage I lung cancer with high-dose vitamin. J Clin Oncol 11: 1216-1222, 1993
30. Lotan R: Cellular biology of the retinoids. In: Degos L, Parkinson DE (eds) Retinoids in Oncology. Springer, Berlin, 1995, pp 27-42
31. Geradts J, Chen J-Y, Russell EK, Yankaskas JR, Nieves L, Minna JD: Human lung cancer cell lines exhibit resistance to retinoic acid treatment. Cell Growth Diff 4: 799-809, 1993
32. Oridate N, Lotan D, Xu X-C, Hong WK, Lotan R: Differential induction of apoptosis by all-trans-retinoic acid and N-(4-hydroxyphenyl)retinamide in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res 2: 855-863, 1996
33. Kalemkerian GP, Slusher R, Ramalingam S, Gadgeel S, Mabry M: Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines. J Natl Cancer Inst 87: 1674-1680, 1995
34. Gudas LJ: Retinoids, retinoid-responsive genes, cell differentiation, and cancer. Cell Growth Diff 3: 655-662, 1992
35. DeLuca LM: Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J 5: 2924-2933, 1991
36. Chambon P: A decade of molecular biology of retinoid acid receptors. FASEB J 10: 940-954, 1996
37. Xu X-C, Ro JY, Lee JS, Shim DM, Hong WK, Lotan R: Diffential expression of nuclear retinoic acid receptors in normal, premalignant, and malignant head and neck tissues. Cancer Res 54: 3580-3587, 1994
38. Lotan R, Xu X-C, Lippman SM, Ro JY, Lee JS, Lee JJ, Hong WK: Suppression of retinoic acid receptor b in oral premalignant lesions and its upregulation by isotretinoin. N Engl J Med 332: 1405-1410, 1995
39. Pfahl M: Nuclear receptor/AP-1 interaction. Endocrin Rev 14: 651-658, 1993
40. Li JJ, Dong ZG, Dawson MI, Colburn NH: Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element. Cancer Res 56: 483-489, 1996